Home
overview

SMi Presents their inaugural conference on...

Pharmaceutical m-Health

About the conference

This conference will provide attendees with vital information on the current market and the opportunity to learn about mobile healthcare strategies from key industry players in this rapidly evolving field. In such an innovative and fast-paced sector, it is essential that you are kept up to date with the numerous ways the pharmaceutical industry can benefit from, and contribute to the increasing mobility of healthcare.

At this inaugural event, attendees will benefit from the unique opportunity to network with senior pharmaceutical executives from the leading organisations in the field as well as learning about a broad range of related issues in technological advancements and novel applications of pharmaceutical mobile healthcare.

The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015*, and therefore represents a major opportunity. The vast potential for mobile phones to change everyday life with their increasing technological capacity to connect people and systems over vast distances, send and receive larger amounts of information, and operate from ever more advanced platforms, affects people and businesses in a variety of ways. Healthcare is certainly no exception, and there are several areas of the pharmaceutical industry that are either undergoing fundamental changes to accommodate and gain from this mobility, or are about to.

*BCC Research, 2011 

 

Key Topics to be Addressed:

Marketing, Sales and CRM: With e-marketing a now long established faucet of promotion, the difference that a mobile personalised service can offer is significant. The opportunities for personalised information delivered through a variety of interactive mediums and devices are ever increasing. In addition, the options that open up to reps in the field as a result of mobile technology are vast, and therefore merit thorough discussion as featured at this event.


Healthcare professionals and communication: How can pharma gain from the fact that a growing percentage of physicians not only own smart phones, but use them regularly in the workplace? Through mobile e-detailing and e-prescribing apps for example, knowledge about products are more easily accessible, as is feedback on those products.    


Anti counterfeiting and developing markets: The pharmaceutical industry looses billions a year from counterfeited goods, and the toll this takes on the health of the patients that use them is made all the more shocking by the fact that developing nations are the most vulnerable to this crime. The increasing usage of mobiles in such countries means that information on how to spot such goods can reach far and wide, as can healthcare information in general


Clinical trials: The possibilities to monitor patients from a distance via mobile connectivity are altering the way trials are conducted, as well as recruitment and retention. Self monitoring in chronic diseases has the potential to save an enormous amount each year.


Adherence: Improving patient adherence is of benefit to patients, healthcare professionals, and pharmaceutical companies themselves. The growing usage of mobile phones to issue medication reminders, and advise on the correct usage of pharmaceutical products, is therefore an exciting new outlet for improving adherence.

   Social media marketing in pharma

 

 

Currently confirmed speakers include:


Luke Raskino, Global New Business Unit Director, Unilever
David Saint Denis
Director Organizational Efficiency, Emerging Markets Merck
Martina Flammer, Senior Medical Director Pfizer
Kai Gait,
Digital Commerce Marketing Manager, GSK
Frank Wartena
Technical Working Group Vice Chair, Continua Healthcare Alliance Research Scientist, Philips Research Europe
Iain Cranston
, Consultant Physician, Queen Alexandra Hospital
Shereen Nabhani
-Gebara Senior lecturer in Pharmacy Practice Kingston University
Ken Grady
Global Head, Business Intelligence & Commercial IT Novartis Vaccines and Diagnostics
Richard Moore
Senior Digital Manager, Digital Marketing, NHS Choices
Peteris Zilgalvis
, Head of Unit, ICT for Health, Directorate General Information Society and Media European Commission
Mohammad Al-Ubaydli
CEO Patients Know Best
Carwyn Jones
Head of Pharmaceutical Sales and Marketing Doctors.net.uk
Jamie Driver
Business Development Manager Medhand International AB
Joelle Sissmann Former VP Global Product Communications Sanofi-Aventis; Cardiologist, Cardiac Rehabilitation Unit, Hopital Corentin Celton
Paul Jones
, Director and Co-leader of Global Life Sciences, Cisco
Robert Istepanian
Professor of Data Communication, Director of Mobile Information and Network Technologies, Kingston University
Paul Berney
, CMO and MD EMEA Mobile Marketing Association
Tim Benjamin, Managing Director, TreatmentTrials.com
David Doherty
CoFounder & Director 3G Doctor
Krishnan Ganapathy
President, Apollo Telemedicine Networking Foundation President, Telemedicine Society of India
Stefan Prebil
, Lead Strategist, MPedigree
Bright Simons
President MPedigree

 

Interested in speaking at the conference?  Contact the Conference Producer.

For sponsorship and exhibition opportunities, Contact our Sponsorship Department.

  

 

Executive Directors, Vice Presidents, Heads, Managers, Team leaders of the following roles:

 

  • Mhealth
  • Telehealth
  • Digital Communications
  • Clinical Trials
  • Recruitment and Retention
  • CRM
  • e-Detailing
  • Social Media,
  • Online Media,
  • eMedia ,
  • Emerging Media
  • Marketing,
  • eMarketing,
  • PR

 

 

  • Digital Marketing,
  • Multi-Channel Marketing
  • Communications,
  • eCommunications,
  • Communications Research
  • Employee Communications/Engagement
  • eBusiness
  • Web Design
  • Content Management
  • Brand Management
  • Product Marketing, Product Development
  • Compliance
  • Business Development
  • Risk Management
  • Global Product Communications

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Rob Istepanian

Rob Istepanian, Director, Mobile Information and Network Technologies Research Centre, Kingston University

9:10 What is ‘m-Health’ and what challenges and opportunities does it offer pharma?

Peteris Zilgalvis

Peteris Zilgalvis, Head of Unit, ICT for Health, Directorate General Information Society and Media, European Commision

  • Differentiating the key stakeholders and channels of communication
  • Identifying the primary areas of potential for pharma
  • Getting to and developing further from pharmaceutical apps
  • The developing regulatory landscape
  • 9:45 ePrescribing Medicines Administration (ePMA) - the future for acute care?

    Chris Wilmarsh

    Chris Wilmarsh, Strategic Accounts Manager, iSoft Plc

    • Key issues with the management of medicines in hospitals
    • Opportunities and challenges for ePrescribing Medicines Administration (ePMA)
    • Providing bedside and mobile access to medicines records

    10:20 Morning Coffee

    10:40 mHealth: The Indian Scenario

    Krishnan Ganapathy

    Krishnan Ganapathy , President, Apollo Telemedicine Networking Foundation - President,, Telemedicine Society of India

  • India stated to be a superpower by 2025 now has a teledensity of 65% and 92% of this is through mobile phone
  • Indians are embracing mobiles with 30% having smart phones
  • The exponential adoption of mBanking, mCommerce & mEntertainment suggests that mHealth cannot be far behind
  • How mHealth may be the only answer to 750 million Indians living in suburban and rural India who have no or very limited access to secondary and tertiary medical care
  • 11:15 Collaborative work in developing markets between pharma, technology providers and governmental organisations

    Johannes  Waltz

    Johannes Waltz, Director, Developing World and MLO Engagement, Pfizer

  • Commerical relevance of using mobile technology to address healthcare barriers
  • SMS for Health – A Multi-sector partnership using mobile phones to improve supply chain management 
  • Collaboration with the World Bank
  • 12:30 Networking Lunch

    13:30 Optimising pharmaceutical products and services through innovative m-health systems

    Rob Istepanian

    Rob Istepanian, Director, Mobile Information and Network Technologies Research Centre, Kingston University

  • The evolving research areas of Mobile healthcare (m-health) and Personalised Healthcare (p-health)
  • How systems biology, Genomic Signal Processing (GSP) and Long Term e-health evolution (LTE-health) will form the pillars of future pharmaceutical research, future systems and drug discovery mechanisms
  • The new research concept of Bio-Communication
  • 14:05 Enabling an ecosystem of connected health solutions through interoperability

    Frank Wartena

    Frank Wartena, Senior Scientist, Healthcare Information Management, Phillips Research

  • Achievements of the Continua Health Alliance
  • The impact on mobile health solutions
  • Opportunities in the development of pharmaceutical products
  • 14:40 The future of mobile internet – Pharma and its role

    Paul  Jones

    Paul Jones, Director and Co-Leader of Global Life Sciences, Cisco

  • Electronic innovation in pharma; from communication to collaboration
  • Measureable benefits to existing systems
  • Success stories in mhealth
  • 15:20 Afternoon Tea

    15:40 How mHealth is transforming the patient experience & the Pharma industry opportunity

    David Doherty

    David Doherty, coFounder, 3G Doctor

  • What are the big mHealth opportunities
  • Why is Mobile Video so transformational?
  • What's happening already and where's the evidence?
  • What's next?
  • 16:15 PANEL DISCUSSION – ADAPTING TO THE CONVERGENCE OF MOBILE TECHNOLOGY IN PHARMA

  • Discussion about the various applications – The realities of their application
  • The increasing permeability of the line between consumer, physician and pharma
  • Enabling cross industry relationships: Consumer healthcare and technology providers example
  • Establishing the real ways ROI can be achieved
  • David Saint Denis

    David Saint Denis, Director, Organizational Efficiency Emerging Markets GBU, Merck Serono

    Adesina  Iluyemi

    Adesina Iluyemi, Co-Founder & Vice-President, MoDise

    Rob Istepanian

    Rob Istepanian, Director, Mobile Information and Network Technologies Research Centre, Kingston University

    Johannes  Waltz

    Johannes Waltz, Director, Developing World and MLO Engagement, Pfizer

    Daniel Morrison-Gardiner

    Daniel Morrison-Gardiner, Healthcare Sales Manager, Research in Motion UK Limited

    16:45 Chairman’s Closing Remarks

    17:00 Drinks reception hosted by BlackBerry

    18:30 Close of day one

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    David Doherty

    David Doherty, coFounder, 3G Doctor

    9:10 Facilitating communication between pharma and the healthcare industry

    Joelle Sissmann

    Joelle Sissmann, Former VP Global Product Communications Sanofi-Aventis, Cardiologist, Cardiac Rehabilitation Unit, Hopital Corentin Celton

  • A dual perspective: Current status and processes
  • The increasing use of mobile devices by healthcare professionals
  • Apps and beyond: How pharma-physician communications can be facilitated
  • The value of product information to pharma and healthcare professionals alike
  • 9:45 Optimizing patient outcomes through Mhealth- The Role of the Pharmacist

  • Department of health’s latest recommendations support the expanded role of community pharmacists in the management of long term conditions.
  • Importance of providing support to patients receiving treatment at home. Case study of Cancer patients
  • How can m Health improve pharmacist’s  involvement in direct patient care in the community 
  • Shereen Nabhani-Gebara

    Shereen Nabhani-Gebara, Senior lecturer in pharmacy practice, Kingston University

    Nada Philip

    Nada Philip, Senior Lecturer, CISM, Kingston University, Kingston University

    Reem  Kayyali

    Reem Kayyali , Principal Lecturer, Kingston University

    10:20 Morning Coffee

    10:40 Leveraging mobile to deliver information and choice

    Richard Moore

    Richard Moore, Senior Digital Manager, Digital Marketing, NHS Choices

  • Why is Mobile integral to NHS Choices in reaching & engaging citizens
  • Health Services via SMS. mobile & apps
  • Success stories
  • Digital convergence and reaching the digitally excluded
  • 11:20 Breaking down barriers

    Gary Monk

    Gary Monk, Managing Director UK, Across Group

  • The top 3 barriers to digital implementation within pharma are, 1) Regulatory concerns (2) Lack of a digital strategy (3) ROI questions
  • With the right approach these barriers can be overcome
  • Experience some practical examples of how to do this
  • 12:00 Networking Lunch

    13:00 Mobile comes of age: the role of the mobile channel in pharma

    Paul Berney

    Paul Berney, CMO and MD EMEA, Mobile Marketing Association

  • The drivers for mobile marketing
  • The international trends
  • How to creating a strategy for mobile
  • 13:40 How m-Health can boost clinical trial patient recruitment, retention and compliance

    Tim Benjamin

    Tim Benjamin, Managing Director, TreatmentTrials.com

  • How mobile can help you communicate better with patients.
  • How capturing patient information via mobile can enhance your data quality.
  • How mobile applications can save your staff time
  • 14:20 Afternoon Tea

    14:40 Raising revenues by putting the patient in control

    Mohammad Al-Ubaydli

    Mohammad Al-Ubaydli, CEO, Patients Know Best

  • Value-added services are possible through patient-controlled medical records
  • Payers are switching to paying for outcomes not pills, so pharmaceutical companies must monitor and improve compliance
  • Research costs are lower and data quality is higher when patients consent to use their working clinical records
  • Mobile user interfaces are key to patient engagement in these services
  • 15:20 Pharmaceutical data through mobile medical diagnostics

    Adesina  Iluyemi

    Adesina Iluyemi, Co-Founder & Vice-President, MoDise

  • Global trend defining mHealth adoption
  • mHealth trend in Africa/Developing Countries
  • Future of mHealth
  • 15:40 Chairman’s Closing Remarks

    +

    The Grange Holborn Hotel

    50-60 Southampton Row
    London WC1B 4AR
    United Kingdom

    The Grange Holborn Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.